| 11.25 0 (0%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.3 | 1-year : | 15.53 |
| Resists | First : | 11.39 | Second : | 13.3 |
| Pivot price | 11.27  |
|||
| Supports | First : | 11.18 | Second : | 11.06 |
| MAs | MA(5) : | 11.23 | MA(20) : | 11.29 |
| MA(100) : | 11.22 |
MA(250) : | 10.97 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 52.5 |
D(3) : | 49.4 |
| RSI | RSI(14): 44.1 | |||
| 52-week | High : | 12.48 | Low : | 10.51 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CBRG ] has closed above bottom band by 34.9%. Bollinger Bands are 37.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.26 - 11.32 | 11.32 - 11.37 |
| Low: | 10.96 - 11.03 | 11.03 - 11.08 |
| Close: | 11.14 - 11.25 | 11.25 - 11.35 |
Chain Bridge I does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus on partnering with a technology company that will advance the United States national security and intelligence interests. The company was incorporated in 2021 and is based in Burlingame, California.
Tue, 23 Jul 2024
$58M Merger: Chain Bridge I Acquires Cannabinoid Medicines Innovator, Eyes Nasdaq Listing - Benzinga
Tue, 23 Jul 2024
Chain Bridge I to acquire Phytanix Bio - TipRanks
Tue, 23 Jul 2024
Chain Bridge I Merger to Form New Nasdaq-Listed HoldCo - TipRanks
Mon, 22 Jul 2024
Chain Bridge I to buy Phytanix Bio - Seeking Alpha
Thu, 18 Jul 2024
(CBRG) Trading Signals - Stock Traders Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 4 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 100 (%) |
| Shares Short | 1 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.25 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -0.8 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 56.25 |
| PEG Ratio | 0 |
| Price to Book value | -45 |
| Price to Sales | 0 |
| Price to Cash Flow | -46.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|